AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34052918 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage IV isolated CAM
Number of subjects: 588
Study 34052918 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage IV non-CAM
Number of subjects: 588
Study 34052918 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage IV CAM plus other distant metastasis
Number of subjects: 588
Study 33190009 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromoxibustion (EM) - 12 sessions over 4 weeks
Number of subjects: 38
Study 33190009 — intervention group
Group type: COMPARATOR
Intervention: Knee health education - 2 sessions
Number of subjects: 38
Study 35437059 — intervention group
Group type: EXPERIMENTAL
Intervention: EDS-FLU 186 µg
Number of subjects: 482
Study 35437059 — intervention group
Group type: EXPERIMENTAL
Intervention: EDS-FLU 372 µg
Number of subjects: 482
Study 35437059 — intervention group
Group type: COMPARATOR
Intervention: EDS-placebo
Number of subjects: 482
Study 33858234 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 hours of intervention per week
Number of subjects: 87
Study 33858234 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 hours of intervention per week
Number of subjects: 87
Study 33858234 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower intensity intervention
Number of subjects: 87
Study 33858234 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher intensity intervention
Number of subjects: 87
Study 33858234 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based comprehensive intervention program
Number of subjects: 87
Study 32632450 — intervention group
Group type: EXPERIMENTAL
Intervention: EOC: 44.1 mg/kg CS
Number of subjects: 80
Study 32632450 — intervention group
Group type: COMPARATOR
Intervention: Control: without MON or EOC added to the calf starter (CS)
Number of subjects: 80
Study 32632450 — intervention group
Group type: EXPERIMENTAL
Intervention: MON: 50.8 mg/kg CS
Number of subjects: 80
Study 32632450 — intervention group
Group type: EXPERIMENTAL
Intervention: MON + EOC
Number of subjects: 80
Study 32632450 — intervention group
Group type: EXPERIMENTAL
Intervention: EOC or MON + EOC
Number of subjects: 80
Study 35501519 — intervention group
Group type: EXPERIMENTAL
Intervention: 755-nm picosecond alexandrite laser with topical tranexamic acid (TTA) combination therapy
Number of subjects: 37
Study 35501519 — intervention group
Group type: COMPARATOR
Intervention: Laser monotherapy
Number of subjects: 37
Study 33902485 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning prediction model (random forest, XGBoost, logistic regression)
Number of subjects: 5508
Study 34865009 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognition (COG)
Number of subjects: 78
Study 34865009 — intervention group
Group type: EXPERIMENTAL
Intervention: Gross Motor Abilities (GMA)
Number of subjects: 78
Study 34865009 — intervention group
Group type: COMPARATOR
Intervention: Aerobic Training (AET)
Number of subjects: 78
Study 32713772 — intervention group
Group type: EXPERIMENTAL
Intervention: Humanoid companion robot (Kabochan)
Number of subjects: 103
Study 32713772 — intervention group
Group type: COMPARATOR
Intervention: Usual standardized care
Number of subjects: 103
Study 33991254 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrolyzed meat protein (HMP)
Number of subjects: 12
Study 33991254 — intervention group
Group type: COMPARATOR
Intervention: Steak
Number of subjects: 12
Study 33991254 — intervention group
Group type: COMPARATOR
Intervention: Minced meat
Number of subjects: 12
Study 33745386 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse coached walking intervention
Number of subjects: 32
Study 33745386 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study 35000945 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulpotec
Number of subjects: 80
Study 35000945 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 80
Study 35000945 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulpotec + PAD
Number of subjects: 80
Study 35000945 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodentine + PAD
Number of subjects: 80
Study 35402989 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol + Granisetron
Number of subjects: 60
Study 35402989 — intervention group
Group type: COMPARATOR
Intervention: Propofol + Metoclopramide
Number of subjects: 60
Study 33830415 — intervention group
Group type: EXPERIMENTAL
Intervention: Contrastive Lexical Approach (CLA)
Number of subjects: 40
Study 33830415 — intervention group
Group type: COMPARATOR
Intervention: Ordinary traditional instruction
Number of subjects: 40
Study 33021563 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine (local anesthetic)
Number of subjects: 0
Study 33021563 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 0
Study 32584651 — intervention group
Group type: EXPERIMENTAL
Intervention: Why-quit messages with distant temporal frames
Number of subjects: 0
Study 32584651 — intervention group
Group type: EXPERIMENTAL
Intervention: Why-quit messages with proximal temporal frames
Number of subjects: 0
Study 32584651 — intervention group
Group type: EXPERIMENTAL
Intervention: How-to-quit messages
Number of subjects: 0
Study 34117867 — intervention group
Group type: EXPERIMENTAL
Intervention: Adiponectin levels
Number of subjects: 0
Study 34117867 — intervention group
Group type: EXPERIMENTAL
Intervention: Mendelian randomization (MR) analyses
Number of subjects: 0
Study 32017863 — intervention group
Group type: EXPERIMENTAL
Intervention: Incubation temperatures of 14°C to 30°C
Number of subjects: 0
Study 33480087 — intervention group
Group type: EXPERIMENTAL
Intervention: MYC-translocated tumors
Number of subjects: 126
Study 33480087 — intervention group
Group type: EXPERIMENTAL
Intervention: BCL6 translocated tumors
Number of subjects: 126
Study 33480087 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster B tumors
Number of subjects: 126
Study 33317479 — intervention group
Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 120
Study 33317479 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 35852487 — intervention group
Group type: EXPERIMENTAL
Intervention: Meaning‐Centered Psychotherapy for Cancer Caregivers (MCP‐C)
Number of subjects: 60
Study 35852487 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Number of subjects: 60
Study 33559413 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib maintenance with pembrolizumab and bevacizumab
Number of subjects: 44
Study 32109293 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir-diphosphate detection
Number of subjects: 201
Study 33482902 — intervention group
Group type: EXPERIMENTAL
Intervention: Human amniotic fluid (hAF)
Number of subjects: 10
Study 33482902 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dose of intravenous hAF (in the last 6 patients)
Number of subjects: 10
Study 33482902 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group not explicitly mentioned)
Number of subjects: 10
Study 32440816 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids at a daily dose of 1000 mg for 30 days
Number of subjects: 452
Study 32440816 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 452
Study 32440816 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids
Number of subjects: 452
Study 34006508 — intervention group
Group type: EXPERIMENTAL
Intervention: Subretinal AAV8.CNGA3 gene therapy
Number of subjects: 9
Study 35002315 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparinoid moisturizer applied during 3 weeks of hypofractionated whole-breast irradiation with or without boost until 4 weeks after completion of irradiation.
Number of subjects: 72
Study 35002315 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment).
Number of subjects: 72
Study 33040631 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum IS-10506 (2 × 10^10 CFU/day)
Number of subjects: 30
Study 33040631 — intervention group
Group type: COMPARATOR
Intervention: Placebo (skim milk-Avicel)
Number of subjects: 30
Study 34030027 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine (administered two hours before assessment)
Number of subjects: 60
Study 34030027 — intervention group
Group type: COMPARATOR
Intervention: Placebo (trough group)
Number of subjects: 60
Study 32760865 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT)
Number of subjects: 377
Study 33880692 — intervention group
Group type: EXPERIMENTAL
Intervention: INCLUSIVE whole-school intervention
Number of subjects: 8179
Study 33880692 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 8179
Study 34477246 — intervention group
Group type: EXPERIMENTAL
Intervention: Music Therapy (MT)
Number of subjects: 0
Study 34477246 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 32170867 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal vincristine with hyper-CMAD
Number of subjects: 31
Study 35610642 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooled radiofrequency ablation (CRFA)
Number of subjects: 0
Study 35610642 — intervention group
Group type: COMPARATOR
Intervention: Intra-articular hyaluronan (HA) injections
Number of subjects: 0
Study 33033846 — intervention group
Group type: EXPERIMENTAL
Intervention: Boss‐Holtzach‐Matter technique
Number of subjects: 58
Study 34404045 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal oil cream
Number of subjects: 135
Study 34404045 — intervention group
Group type: COMPARATOR
Intervention: Calcipotriol (0.05%)
Number of subjects: 135
Study 34404045 — intervention group
Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 135
Study 32361843 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon Kyphoplasty (BKP)
Number of subjects: 139
Study 32361843 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous Vertebroplasty (PVP)
Number of subjects: 139
Study 36075246 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab 420 mg monthly with background statins with or without ezetimibe for 80 weeks
Number of subjects: 150
Study 36075246 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab 420 mg monthly
Number of subjects: 150
Study 34810387 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant therapy containing natural lycopene with green tea extract
Number of subjects: 48
Study 34810387 — intervention group
Group type: COMPARATOR
Intervention: Full mouth scaling and root planing (Control)
Number of subjects: 48
Study 32865079 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-Delivered Brief Intervention (CDBI) with various components (animated narrator, spoken voice, empathic reflections, motivational interviewing)
Number of subjects: 352
Study 32865079 — intervention group
Group type: COMPARATOR
Intervention: Computer-Delivered Brief Intervention (CDBI) without specific components
Number of subjects: 352
Study 36099282 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized biological feedback related to physical activity behaviors
Number of subjects: 50
Study 36099282 — intervention group
Group type: COMPARATOR
Intervention: Standard educational material
Number of subjects: 50
Study 34202314 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine 30 mg once a day
Number of subjects: 39
Study 34202314 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 34495340 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-Release Buprenorphine (XRB)
Number of subjects: 52
Study 34495340 — intervention group
Group type: COMPARATOR
Intervention: Daily Sublingual Buprenorphine-Naloxone (SLB)
Number of subjects: 52
Study 33283485 — intervention group
Group type: EXPERIMENTAL
Intervention: AKCEA‐TTR‐LRx 45 mg
Number of subjects: 0
Study 33283485 — intervention group
Group type: EXPERIMENTAL
Intervention: AKCEA‐TTR‐LRx 60 mg
Number of subjects: 0
Study 33283485 — intervention group
Group type: EXPERIMENTAL
Intervention: AKCEA‐TTR‐LRx 90 mg
Number of subjects: 0
Study 33283485 — intervention group
Group type: EXPERIMENTAL
Intervention: AKCEA‐TTR‐LRx 120 mg (single dose)
Number of subjects: 0
Study 33283485 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35123014 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT) with different illumination times
Number of subjects: 70
Study 35123014 — intervention group
Group type: COMPARATOR
Intervention: Control group (no illumination)
Number of subjects: 70
Study 32588418 — intervention group
Group type: EXPERIMENTAL
Intervention: Monofilament synthetic absorbable sutures
Number of subjects: 95
Study 32588418 — intervention group
Group type: COMPARATOR
Intervention: Multifilament synthetic absorbable sutures
Number of subjects: 95
Study 35559241 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplements
Number of subjects: 80
Study 35559241 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 32679755 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D moving platform exercise (3DEG)
Number of subjects: 29
Study 32679755 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 29
Study 35426781 — intervention group
Group type: EXPERIMENTAL
Intervention: i-gel® (supraglottic airway)
Number of subjects: 9296
Study 35426781 — intervention group
Group type: COMPARATOR
Intervention: Tracheal intubation
Number of subjects: 9296
Study 34258270 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 121
Study 34258270 — intervention group
Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 121
Study 35895098 — intervention group
Group type: EXPERIMENTAL
Intervention: Gefapixant 45 mg twice daily
Number of subjects: 1360
Study 35895098 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1360
Study 35124914 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg
Number of subjects: 100
Study 35124914 — intervention group
Group type: COMPARATOR
Intervention: Dapagliflozin 10 mg
Number of subjects: 100
Study 34253679 — intervention group
Group type: EXPERIMENTAL
Intervention: LCA-derived subphenotypes (hyperinflammatory subphenotype)
Number of subjects: 959
Study 34253679 — intervention group
Group type: EXPERIMENTAL
Intervention: LCA-derived subphenotypes
Number of subjects: 959
Study 34253679 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of novel biomarkers
Number of subjects: 959
Study 34847699 — intervention group
Group type: EXPERIMENTAL
Intervention: Hip exercises
Number of subjects: 218
Study 34847699 — intervention group
Group type: COMPARATOR
Intervention: Foot orthoses
Number of subjects: 218
Study 33301646 — intervention group
Group type: EXPERIMENTAL
Intervention: POLST specifying 'CPR'
Number of subjects: 57
Study 33301646 — intervention group
Group type: COMPARATOR
Intervention: No Document
Number of subjects: 57
Study 33301646 — intervention group
Group type: EXPERIMENTAL
Intervention: POLST/ do not resuscitate-comfort measures only (DNR-CMO)
Number of subjects: 57
Study 33301646 — intervention group
Group type: EXPERIMENTAL
Intervention: LW or POLST specifying DNR combined with medical support
Number of subjects: 57
Study 33301646 — intervention group
Group type: EXPERIMENTAL
Intervention: Documents (LW or POLST)
Number of subjects: 57
Study 33301646 — intervention group
Group type: COMPARATOR
Intervention: No Document and POLST/CPR
Number of subjects: 57
Study 33301646 — intervention group
Group type: EXPERIMENTAL
Intervention: POLST DNR/Limited Treatment
Number of subjects: 57
Study 33301646 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior training in LWs and POLST
Number of subjects: 57
Study 35733519 — intervention group
Group type: EXPERIMENTAL
Intervention: Training plus spirulina (T+S)
Number of subjects: 60
Study 35733519 — intervention group
Group type: COMPARATOR
Intervention: Training plus placebo (T+P)
Number of subjects: 60
Study 35733519 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirulina (S)
Number of subjects: 60
Study 35733519 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 60
Study 33775313 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab (BEV)
Number of subjects: 0
Study 33775313 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment of BEV and Stupp protocol
Number of subjects: 0
Study 33049412 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mA tDCS stimulation for 20 minutes during a two-week cognitive training intervention
Number of subjects: 14
Study 33049412 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mA tDCS stimulation
Number of subjects: 14
Study 36243317 — intervention group
Group type: EXPERIMENTAL
Intervention: Development of a taxonomy for acute needle pain based on a 5-dimensional structure.
Number of subjects: 0
Study 33137868 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor imagery-based training program
Number of subjects: 27
Study 33137868 — intervention group
Group type: COMPARATOR
Intervention: Control group (watching videos about the history of the Olympic Games)
Number of subjects: 27
Study 34991426 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum Ca-125 levels
Number of subjects: 0
Study 34991426 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal lavage fluid Ca-125 levels
Number of subjects: 0
Study 33678218 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional warnings (black octagonal signs with the word 'Excess')
Number of subjects: 447
Study 33678218 — intervention group
Group type: COMPARATOR
Intervention: Control (no nutritional warnings)
Number of subjects: 447
Study 35086570 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat flour with pulses
Number of subjects: 42
Study 35086570 — intervention group
Group type: COMPARATOR
Intervention: Rice flour with pulses
Number of subjects: 42
Study 35086570 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat flour meal
Number of subjects: 42
Study 35086570 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen production
Number of subjects: 42
Study 33866072 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% THC cannabis concentrate
Number of subjects: 65
Study 33866072 — intervention group
Group type: EXPERIMENTAL
Intervention: 90% THC cannabis concentrate
Number of subjects: 65
Study 33866072 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad libitum cannabis concentrate use
Number of subjects: 65
Study 35586118 — intervention group
Group type: EXPERIMENTAL
Intervention: PR maintenance via social media supervision at home (Group A)
Number of subjects: 140
Study 35586118 — intervention group
Group type: EXPERIMENTAL
Intervention: PR maintenance at hospital (Group B)
Number of subjects: 140
Study 35586118 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Group C)
Number of subjects: 140
Study 33798499 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV-19 (AZD1222) vaccine
Number of subjects: 8534
Study 33798499 — intervention group
Group type: COMPARATOR
Intervention: Meningococcal conjugate control (MenACWY) vaccine
Number of subjects: 8534
Study 33164953 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurorestoration protocol (n=32) for 7 days
Number of subjects: 64
Study 33164953 — intervention group
Group type: COMPARATOR
Intervention: Conventional physiotherapy (n=32) for 7 days
Number of subjects: 64
Study 33794672 — intervention group
Group type: EXPERIMENTAL
Intervention: RFQY-5 (shortened version of the Reflective Function Questionnaire for Youth)
Number of subjects: 1204
Study 33794672 — intervention group
Group type: EXPERIMENTAL
Intervention: RFQY-5
Number of subjects: 1204
Study 33794672 — intervention group
Group type: COMPARATOR
Intervention: Original 23-item RFQY
Number of subjects: 1204
Study 32869124 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 g TXA
Number of subjects: 325
Study 32869124 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0 g TXA
Number of subjects: 325
Study 32869124 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.0 g TXA
Number of subjects: 325
Study 32869124 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 g TXA
Number of subjects: 325
Study 32869124 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 325
Study 34345377 — intervention group
Group type: EXPERIMENTAL
Intervention: TF-reg protocol (10 assignments)
Number of subjects: 224
Study 34345377 — intervention group
Group type: COMPARATOR
Intervention: TF-short protocol (6 assignments)
Number of subjects: 224
Study 34345377 — intervention group
Group type: EXPERIMENTAL
Intervention: Both conditions
Number of subjects: 224
Study 34599466 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacillus coagulans Unique IS2 with lactulose (15 mL suspension of probiotic (B. coagulans Unique IS2, 2 × 10^9 spores) with lactulose (10 g))
Number of subjects: 150
Study 34599466 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacillus coagulans Unique IS2 with lactulose
Number of subjects: 150
Study 34599466 — intervention group
Group type: COMPARATOR
Intervention: Lactulose (10 g)
Number of subjects: 150
Study 34599466 — intervention group
Group type: COMPARATOR
Intervention: Placebo (water)
Number of subjects: 150
Study 33128483 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupervised learning-based MTC–MR fingerprinting
Number of subjects: 6
Study 33128483 — intervention group
Group type: COMPARATOR
Intervention: Conventional Bloch fitting approach
Number of subjects: 6
Study 33005046 — intervention group
Group type: EXPERIMENTAL
Intervention: Incisionless lacrimal dilator-facilitated STB (Group LD)
Number of subjects: 63
Study 33005046 — intervention group
Group type: COMPARATOR
Intervention: Standard STB using Wescott scissors and blunt forceps (Group WS)
Number of subjects: 63
Study 32452846 — intervention group
Group type: EXPERIMENTAL
Intervention: Early revascularization (PCI confined to the culprit lesion)
Number of subjects: 0
Study 32452846 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous P2Y12 inhibitor cangrelor
Number of subjects: 0
Study 32452846 — intervention group
Group type: COMPARATOR
Intervention: Emergency coronary artery bypass grafting (CABG)
Number of subjects: 0
Study 34679399 — intervention group
Group type: EXPERIMENTAL
Intervention: Active transcranial direct current stimulation
Number of subjects: 80
Study 34679399 — intervention group
Group type: COMPARATOR
Intervention: Sham transcranial direct current stimulation
Number of subjects: 80
Study 36239434 — intervention group
Group type: EXPERIMENTAL
Intervention: No-cost cryotherapy treatment
Number of subjects: 81
Study 36239434 — intervention group
Group type: EXPERIMENTAL
Intervention: Transportation costs and long distances to the hospital
Number of subjects: 81
Study 36239434 — intervention group
Group type: EXPERIMENTAL
Intervention: Work, household obligations, and fear of treatment
Number of subjects: 81